Influenza: Immunization to new age groups;Influenza: Vacunación a nuevos grupos etarios

Revista Chilena de Infectologia

Volumn 24, Issue 3, 2007, Pages 227-230

  Abarca Villaseca, Katia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Children; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; CHILE; HUMAN; INFANT; INFLUENZA; MIDDLE AGED; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; REVIEW; VACCINATION;

ADULT; AGED; CHILD, PRESCHOOL; CHILE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; VACCINATION;

EID: 34250314180     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Bridges C B, Winquist A G, Fukuda K, Cox N J, Singleton J A, Strikas R A; Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49 (RR-3): 1-38.
2. Bridges C B, Harper S A, Fukuda K, Uyeki T M, Cox N J, Singleton J A; Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003; 52 (RR-8): 1-34.
3. Harper S A, Fukuda K, Uyeki T M, Cox N J, Bridges C B; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004; 53 (RR-6): 1-40.
4. Centers for Disease Control and Prevention. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults. Colorado, 2003. MMWR Morbid Mortal Wkly Rep 2004; 53: 707-10.
5. Izurieta H S, Thompson W W, Kramarz P, Shay D K, Davis R L, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-9.
6. Quach C, Piche-Walker L, Platt R, Moore D. Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics. 2003; 112: e197-201.
7. Delpiano L, Byron G, Casado C. Comportamiento clínico- epidemiológico de la influenza en niños hospitalizados. Rev Chil Infectol 2003; 20: 159-65.
8. Gruber W C, Taber L H, Glezen W P, Clover R D, Abell T D, Demmler R W, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990; 144 (5): 595-600.
9. Piedra P A, Glezen W P, Mbawuike I, Gruber W C, Baxter B D, Boland F J, et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine 1993; 11: 718-24.
10. Khan A S, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, et al. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian school children. J Infect Dis 1996; 173: 453-6.
11. Neuzil K M, Dupont W D, Wright P F, Edwards K M. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001; 20: 733-40.
12. Edwards K M, Dupont W D, Westrich M K, Plummer W D Jr, Palmer P S, Wright P F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169: 68-76.
13. France E K, Glanz J M, Xu S, Davis R L, Black S B, Shinefield H R, et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med 2004; 158: 1031-6.
14. Kramarz P, Destefano F, Gargiullo P M, Chen R T, Lieu TA, Davis RL, et al; Vaccine Safety Datalink Team. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138: 306-10.
15. Chen R T, DeStefano F, Davis R L, Jackson L A, Thompson R S, Mullooly J P, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Org 2000; 78: 186-94.
16. McMahon A W, Iskander J, Haber P, Chang S, Woo E J, Braun M M, et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics 2005; 115: 453-60.
17. Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005; 23: 1851-61.
18. Zangwill K M, Belshe R B. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004; 23: 189-200.
19. Poehling K A, Speroff T, Dittus R S, Griffin M R, Hickson G B, Edwards K M. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics 2001; 108: e99.
20. Heikkinen T, Ruuskanen O, Waris M, Zieger T, Arola M, Halonen P. Influenza vaccination in the prevention of otitis media in children. AJDC 1991; 145: 445-8.
21. Clements D A, Langdon L, Bland C, Emmanuel W. Influenza vaccine decreases incidence of otitis media in 6-30 month-old children in day care. Arch Pediatr Adolesc Med 1995: 149; 1113-7.
22. Hoberman A, Greenberg D P, Pardise J L, Rockette H E, Lave J R, Keraney D et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children. JAMA 2003; 290: 1608-16.
23. Longini I M, Halloran M E, Nizam A, Wolff M, Mendelman P M, Fast P E, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 2000 Mar 17; 18: 1902-9.
24. Weycker D, Edelsberg J, Halloran M E, Longini I M, Nizam A, Ciuryla V, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23: 1284-93.
25. Piedra P A, Gaglani M J, Kozinetz C A, Herschler G, Riggs M, Griffith M, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23: 1540-8.
26. Reichert T A, Sugaya N, Fedson D S, Glezen W P, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889-96.
27. White T, Lavoie S, Nettleman M D. Potential cost savings attributable to influenza vaccination in school-aged children. Pediatrics 1999; 103: e73.